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A Multi-national Pooled Analysis of 434 Cases 
of Stage I Non-small Cell Lung Cancer (NSCLC) 
Treated with Volumetrically Image-guided 
Stereotactic Lung Radiotherapy: Results from 
the Elekta Collaborative Lung Research Group
Background
Published lung SBRT outcomes/dose response data for inoperable 
NSCLC come from small phase I-II studies or larger datasets 
not requiring image-guided radiotherapy (IGRT) or volumetric 
prescriptions. This entire cohort of SBRT patients had daily online 
cone-beam CT.
Materials/Methods
Four-hundred-thirty-four (434) cases of Stage I (T1-2N0M0) NSCLC 
were treated with SBRT via VIGRT at 1/5 institutions from 1998-
2009. Median age was 74y (42-92); 53% male, 47% female. Median 
FEV1 was 1.4L (65% predicted); median DLCO was 9.8 ml/min/
mmHg (54% predicted). Sixty-two percent (62%) of tumors were 
biopsy-proven; 84% of cases were staged with CT and PET. Clinical 
stage was IA in 76%, IB in 22%, locally recurrent in 1%. Median max 
tumor dimension was 2.4cm (0.9- 8.5cm). Histologies were: 41% 
adenocarcinoma, 34% squamous, 12% large cell, 13% NSCLC. NOS. 
8%, 51%, and 42% were grades 1, 2, 3. Median volumetric prescription 
dose (PD) was 54Gy (20-64Gy) delivered in median of 3 fractions (fx) 
(1-15fx) over 8d (1-27d). Median biological equivalent PD (BED10) 
was 132Gy (60-180Gy), equal to 2-Gy fx equivalent (FE) of 110Gy 
(50-150Gy). Corresponding GTV and PTV mean doses (2-GyFE) 
were 157Gy and 137Gy. Mean follow-up was 1.3y (0.1-7.3y).
Results
2-y Kaplan-Meier rates of local recurrence (LR), regional recurrence 
(RR) and distant metastasis (DM) were 8%, 13%, and 26%. Two year 
overall survival(OS) and cause-specific survival(CSS) were 58% and 
84%. No statistically significant differences in LR, RR, DM, OS or CSS 
were identified for biopsied vs. non-biopsied tumors. On univariate 
analysis, stage (IA 5% v IB 16%, p=0.002), GTV max dimension (<2.7cm 
4% v ≥2.7cm 12%, p=0.006), and 2-GyFE PD (<88Gy 17% v ≥88Gy 5%, 
p<0.001) predicted LR. GTV (<115Gy 32% v ≥115Gy 4%, p<0.001) and 
PTV (<105Gy 24% v ≥105Gy 4%, p<0.001) mean doses also predicted 
LR. Cox multiple regression confirmed the relationship between PD and 
LR, independent of GTV size (p=0.01).
Conclusion
This is the first Lung SBRT dataset of patients treated uniformly with 
daily online VIGRT and resulted in excellent local control for Stage 
I NSCLC. A 2-GyFE dose of 88 Gy predicted superior local control.
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